Open AccessA Phylogenetic Analysis of Hepatitis C Virus Transmission, Relapse, and Reinfection Among People Who Inject Drugs Receiving Opioid Agonist Therapy
Author(s) -
Matthew J. Akiyama,
Daniel Lipsey,
Lilia Ganova-Raeva,
Lili Punkova,
Linda Agyemang,
Amanda Sue,
Sumathi Ramachandran,
Yury Khudyakov,
Alain H. Litwin
Publication year - 2020
Publication title -
the journal of infectious diseases (online. university of chicago press)/the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1093/infdis/jiaa100
Subject(s) - medicine , transmission (telecommunications) , cohort , harm reduction , virology , hypervariable region , hepatitis c virus , psychological intervention , hepatitis c , viral load , outbreak , immunology , virus , psychiatry , antibody , human immunodeficiency virus (hiv) , electrical engineering , engineering
Understanding hepatitis C virus (HCV) transmission among people who inject drugs (PWID) is essential for HCV elimination. We aimed to differentiate reinfections from treatment failures and to identify transmission linkages and associated factors in a cohort of PWID receiving opioid agonist therapy (OAT).